An ATP-dependent potassium channel blocker antagonizes morphine analgesia.
Ocaña
M
M
Department of Pharmacology, Medical School, Granada University, Spain.
Del Pozo
E
E
Barrios
M
M
Robles
L I
LI
Baeyens
J M
JM
D000255:Adenosine Triphosphate / Q000502:physiology*; D000698:Analgesia; D000818:Animals; D005260:Female; D005905:Glyburide / Q000008:administration & dosage / Q000494:pharmacology*; D007276:Injections, Intraventricular; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors*; D010147:Pain Measurement; D015221:Potassium Channels / Q000187:drug effects*; D011803:Quinine / Q000494:pharmacology; D019789:Tetraethylammonium; D013757:Tetraethylammonium Compounds / Q000494:pharmacology
D015221:Potassium Channels; D013757:Tetraethylammonium Compounds; D019789:Tetraethylammonium; D009020:Morphine; D000255:Adenosine Triphosphate; D011803:Quinine; D005905:Glyburide